PROCEPT BioRobotics is a privately held medical device company based in the heart of Silicon Valley developing a novel minimally invasive technology for the surgical treatment of prostate disease. PROCEPT’s AquaBeam combines image guidance and robotics to deliver Aquablation, a waterjet ablation therapy that enables targeted, controlled, and heat-free removal of tissue for the treatment of lower urinary tract symptoms as a result of benign prostatic hyperplasia (BPH).